Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
5
×
biotech
national top stories
pfizer
san francisco blog main
amgen
boston blog main
boston top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
startups
abbvie
adverum biotechnologies
alzheimer's disease
boulder/denver blog main
boulder/denver top stories
cystic fibrosis
deals
detroit blog main
detroit top stories
diagnostics
gilead sciences
indiana blog main
indiana top stories
merck
novartis
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acute myeloid leukemia
What
ceo
5
×
drug
5
×
acquisitions
announced
biggest
bio
medicine
pfizer
roundup
week
year
aces
albert
alex
athena
big
biotech
bourla
build
buy
cancer
chief
cholesterol
collaboration
company
company’s
countouriotis
crispr
daniel
debut
discovery
dyne’s
entered
financing
flexible
future
gets
gilead
imports
inclisiran
Language
unset
unknown
Current search:
" national blog main "
×
drug
×
ceo
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push